BackShanghai Pharmaceuticals Holding , Ltd Overview
Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding , Ltd Return on Equity

Shanghai Pharmaceuticals Holding , Ltd (SHPMF) has a ROE of 6.08%, below the sector sector average of 11.64%.

Get informed when a big investor buys or sells

+ Follow

ROE

6.08%

Return on Equity

6.08%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Shanghai Pharmaceuticals Holding , Ltd (SHPMF) FAQ

Shanghai Pharmaceuticals Holding , Ltd's return on equity stands at 6.08%. That is below the sector sector average of 11.64%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Shanghai Pharmaceuticals Holding , Ltd sits lower the its sector benchmark (11.64%) with a ROE of 6.08%. That is roughly 47.8% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 6.08% for Shanghai Pharmaceuticals Holding , Ltd means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Shanghai Pharmaceuticals Holding , Ltd's ROE evolved across reporting periods, while the comparison chart places SHPMF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.